Author: SmartStocks.ca Staff
-
TKO Group Doubles Dividend, Signals Long-Term Confidence
Dividend stocks with lower yields aren’t necessarily poor picks for income-focused investors—especially when backed by strong financials and a track record (or clear intention) of payout growth. TKO Group Holdings (NYSE:TKO), the parent company of UFC and WWE, just delivered a strong signal of confidence by doubling its quarterly dividend from $0.38 to $0.76 per Read more
-
Will Tariffs Weigh Down Shopify’s Stock?
Key Items: Shopify (TSX:SHOP)(NASDAQ:SHOP) has built a global e-commerce ecosystem that empowers merchants to sell goods and services—often without needing their own website. Its strong international sales momentum has helped drive consistent revenue growth, but new trade policy shifts may pose a significant challenge. With the U.S. ending the de minimis rule, which previously allowed Read more
-
BigBear.ai Stock Falls on Big Earnings Miss and Guidance Cut
Shares of data analytics stock BigBear.ai (NYSE:BBAI), which some investors see as potentially being the next Palantir Technologies (NASDAQ:PLTR), nosedived on Tuesday after the company released its latest earnings numbers. What has gotten investors so bearish on the stock? Here are the 5 most important numbers from BigBear’s earnings report. $32.5 million in sales. Revenue Read more
-
Tilray Stock Jumps Over 40% in Monday: What’s Behind the Surge?
Shares of Tilray Brands (NASDAQ:TLRY) soared more than 40% on Monday, back to around the levels they were at in February of this year. And in after-hours trading, it was up over 10%. Up until recently, it was looking like it would be another brutal year for the cannabis and beverage stock. Why has Tilray Read more
-
Shopify Becomes Most Valuable Canadian Stock After Strong Q2 Earnings Report
Shopify (TSX:SHOP)(NASDAQ:SHOP) is once again in the spotlight after delivering a blockbuster second‑quarter 2025 report. On August 6, the company released its latest numbers, and the Ottawa‑based e‑commerce giant posted net income of $906 million as revenue jumped 31% to $2.68 billion — beating analyst expectations of $2.55 billion. The growth was broad‑based: subscription solutions and merchant Read more
-
Air Canada Slides After Weak Earnings and Rising Costs Pressure Margins
Key Numbers Air Canada (TSX:AC) shares have come under pressure following a mixed second-quarter earnings report. Although revenue for the quarter ending June 30 climbed 2% to $5.6 billion, net income plummeted to $186 million—less than half of the $410 million posted a year earlier. The sharp drop in profitability was primarily driven by margin Read more
-
Telus Announces a $2 Billion Investment and Locks Up a Deal with Cogeco
On July 21, 2025, Canadian telecom operator Telus (TSX:T)(NYSE:TU) announced that it will invest $2 billion over the next five years to enhance its broadband and 5G networks across Ontario and Québec. The initiative aims to deliver “global‑leading broadband services” to communities in the country’s two largest provinces. The company has also revealed that it has secured Read more
-
Canadian National Railway’s Business Shows Resilience in Q2 but Question Marks About Its Future Remain
Canadian National Railway (TSX:CNR)(NYSE:CNI) recently reported its second quarter results of fiscal 2025, which wasn’t great but wasn’t all that troubling, either. CN reported that revenue ton miles—a key measure of freight volume—fell about 1% to 59.2 billion. The decline reflects softer demand for bulk commodities and consumer goods amid slower economic growth. The company also revealed Read more
-
Loblaw Posts Strong Quarterly Results but a Controversy Emerges Around Its ‘Buy Canada’ Marketing
Grocery heavyweight Loblaw (TSX:L) recently delivered earnings results in July. The company reported that Q2 revenue climbed 5.2 % to $14.7 billion—roughly $725 million more than the same period a year earlier. Analysts had been looking for growth closer to 5 % and sales of roughly $14.6 billion, so Loblaw’s numbers beat expectations. The company continues to benefit from high Read more
-
GLP-1 Drugs: A Promising Study Suggests They Could Help Treat Cancer
GLP-1 therapies are rapidly transforming diabetes and weight-loss treatment, new research suggests they could also weaken cancer growth, and Eli Lilly (NYSE:LLY)’s tirzepatide stands to gain if these findings hold up. In a recent mouse experiment, scientists gave obese animals tirzepatide—Lilly’s blockbuster obesity and diabetes drug—and watched not only a roughly 20% drop in body Read more